The Nation - News from Aug. 30, 1985
Researchers reported in the British journal Nature that they have taken a major stride toward identifying the genetic defect that causes the most common form of deadly muscular dystrophy. The work by a team at Children’s Hospital in Boston may help lead to development of a treatment for Duchenne muscular dystrophy, other experts said. In addition, it will provide a better test for finding carriers of the defect that causes the disease and for performing prenatal diagnosis, the experts said.
More to Read
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.